Chaya Moroz
Molecular Immunology Unit
Felsenstein Medical Research Center
Rabin Medical Centre
Sackler Faculty of Medicine
Israel
Name/email consistency: high
- Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks. Moroz, C., Grunspan, A., Zahalka, M.A., Traub, L., Kodman, Y., Yaniv, I. Exp. Hematol. (2006)
- PLIF, a novel human ferritin subunit from placenta with immunosuppressive activity. Moroz, C., Traub, L., Maymon, R., Zahalka, M.A. J. Biol. Chem. (2002)
- Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component. Moroz, C., Maymon, R., Jauniaux, E., Traub, L., Cuckle, H. Prenat. Diagn. (2000)